Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHAR · BSE: 524632 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹68.47
Market cap: ₹3,010 Cr
Revenue (annual): ₹56.73 Cr
Net profit (annual): ₹22.06 Cr
P/E (TTM): 88.6×Sector 47.3×
Promoter holding: 51.15%+0.19% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Other Announcement 4 Board Meeting Date 4 Financial Results 3 Fund Raise 2 Capital Structure Change 2 Board Meeting Outcome 2 SME to Main Board Migration 1 Merger & Restructuring 1 Management Change 1 Dividend 1 Debt & Borrowing 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Aug 2026 14:46 IST NSE

Board Meeting Outcome

Shukra Pharmaceuticals Board Meeting Outcome

Shukra Pharmaceuticals announced the board's approval to change its name to 'Shukra Medtech Limited', alter its main objects, and convene the 33rd Annual General Meeting.

Read the filing ↗

14 Aug 2026 15:18 IST BSE

Board Meeting Outcome

Shukra Pharmaceuticals Board Meeting Outcome

Shukra Pharmaceuticals' board approved changing the company name to Shukra Medtech Limited. The board also expanded the company's main business objects to include medical technology activities.

Read the filing ↗